|Publication number||USRE37274 E1|
|Application number||US 09/078,831|
|Publication date||Jul 10, 2001|
|Filing date||May 14, 1998|
|Priority date||May 2, 1994|
|Also published as||US5516517|
|Publication number||078831, 09078831, US RE37274 E1, US RE37274E1, US-E1-RE37274, USRE37274 E1, USRE37274E1|
|Inventors||John P. Gardner|
|Original Assignee||John P. Gardner|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (17), Referenced by (3), Classifications (61), Legal Events (3)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This invention relates to a process and treating solution for the nutritional oxygenation of the skin via the steps of exfoliation, cleansing, hydration, and oxygenation. The steps of the process are performed by using various solutions that are adjusted to specific pH levels to condition the skin and allow the skin to receive each level of nutrients on a pore-by-pore basis.
Oxygen is a critical element in the maintenance of healthy skin, just as it is crucial to the normal functioning of our bodies in general. The use of oxygen to increase the healing of skin wounds caused by disease or injury is well documented by medical researchers, clinicians, and physicians around the world. The majority of this documentation is found in textbooks and literature detailing hyperbaric oxygenation as well as oxygenated limb pressure units. So far, however, there has been a limited number of programs established that are clinically advanced enough to use oxygen cosmetic skin treatments.
The proper use of oxygen is even more important considering that there are more than ninety harmful contaminants dumped into the air every day that are detrimental to the skin. Under certain conditions, skin is porous and will allow the passage of certain molecular contaminants, many of which are lyophilic and can remain on subcutaneous fat for a considerable length of time. Medical authorities have documented alarming increases in virtually every type of skin cancer known since the proliferation of many of these toxic airborne contaminants.
Traditional practices of skin care in the prior art have been very limited. The emphasis has been placed on cleansing and cosmetics, rather than prevention and treatment. As a result, the prior art provided only short-term relief with no lasting benefit to the skin. In fact, many methods currently employed are damaging to facial skin and are thus undesirable.
Specifically, the problem of moisturizing the skin with the currently available creams, oils and lotions is that many of the ingredients used therein clog the pores and may cause infection to occur. Also, complete and effective moisturization of the skin is not entirely possible due to the size and structure of the molecules in the lotions, oils and creams.
There have only been a few programs established that are clinically advanced enough to use oxygen via a cosmetic means. Cosmetic oxygenation of normal skin serves the purpose of increasing topical nutrition and acids in the prevention or retardation of the degenerative process. Cosmetic oxygenation may also be successfully used to reduce the negative effects of skin degeneration caused by atmospheric contaminations.
The fundamental principle underlying the present invention is to deter the negative impact of minute particles that may become embedded in the skin and subsequently destroy the skin cells. The process of the present invention is designed to cause the skin to become a semi-permeable membrane by the topical application of various solutions that are pH adjusted within a predetermined range. By placing these pH adjusted solutions on the skin at various intervals, and massaging vitamins and minerals directly onto the skin's surface, the skin will be encouraged to respond topically and accept an oxygenated mist of moisturized nutrients into the skin.
It is therefore a primary objective of this invention to provide a skin care treatment that will provide a strong nutrient base for the care of the skin that will include the use of the oxygen molecule.
A further objective of the present invention is to add an abundance of moisturized nutrients composed of vitamins, minerals, enzymes, amino acids, and oxygen into tile skin.
It is a further objective of the present invention to effect a greater deposition of submicronic nutrients to the skin cells on a pore-by-pore basis.
A still further objective of the present invention is to reduce the intrinsic and extrinsic aging process by increasing the tensillary strength of the underlying skin cells.
The method and manner of accomplishing each of the above objectives as well as others will become apparent from the detailed description of the invention which follows.
A process of exfoliation, cleansing, hydration, and oxygenation is used to provide nutritional oxygenation of the skin. To begin, a two step exfoliation process consists of first using an alkalinic solution to break down skin cells immediately on contact, then using a slightly acidic solution to help neutralize the alkalinic solution and calm the skin. Second, the cleansing step uses a bacteriostatic agent to tone the skin and to make the skin a “sterile” environment. Third, the hydration step uses applied vitamins and minerals to create a semi-permeable keratinized layer which adapts the skin to receive higher amounts of nutrients. Finally, the oxygenation step saturates each pore with oxygen so that the skin will absorb a select amount of molecular nutrients on a pore-by-pore basis.
This invention is a process consisting of the steps of exfoliating the skin, cleansing the skin, hydrating the skin, and oxygenating the treated area. In general, exfoliation is accomplished by first applying an alkalinic solution to the facial area, followed by an application of an acidic solution as a neutralizer. Cleansing of the skin is accomplished by applying a solution containing a bacteriostatic agent. To hydrate the skin, select amounts of vitamins A and E and minerals are applied to the skin. Finally, the skin is oxygenated with a nebulizer thereby providing nutrients to the skin on a pore-by-pore basis.
The first part of this process utilizes an Exfoliant I solution. It is titrated to be an alkalinic solution with a pH substantially in the range of 8.2 to 8.5. The method of operation is purely enzymatic (and enhancement ) with base line surfactants. The solution is a combination of mild enzymatic cleansing agents and an electrolyte soap. Enzymes useful include protolific enzymes such as papain, 0.2-0.5% hydrolytic enzymes such as bromelain 0.3-0.7% and citrus fruit extracts which contain other digestive enzymes in an amount of 0.2 -0.5%. These enzymes are traditionally used in meat tenderizing. Next the solution includes an electrolytic cleansing agent such as potassium chloride soap in an amount of 28-34%. Various moisturizers such as aloe vera may be added in amounts of 8-12%. Optionally the solution may include an emulsion stabilizer oil-base substance such as almond oil.
Finally the pH of the solution is adjusted by addition of a saline solution to 8.2 to 8.5. A solution according to this step was prepared and is listed below. The ingredient, its purpose, is contemplated percentage, and is approximate useful range by percentage by weight is as follows:
Saline (.9% NA)
H2O or Demineralized
This solution is then applied to the face to condition the skin, in preparation for the next acidic application. In the preferred embodiment, the solution is massaged into the skin to enhance absorption.
An example procedure for using the Exfoliant I solution is as follows: First, shake the Exfoliant I solution well. Place 1-2cc's of the Exfoliant I solution on a clean exfoliant pad and begin to apply to the facial area of the user from the neck up. Eye makeup, such as mascara, may be removed from the eyes with the soaked pad. It is important to be careful not to rub the solution into the eyes. Some users may require a second application of the Exfoliant I if makeup cannot be completely removed. Second, 1-2cc's of the Exfoliant I solution are massaged into the skin with slow, controlled strokes. As the solution is worked into the skin, it will begin to loosen and slip on the skin's surface. This step is for exfoliation, although lymphatic drainage may be done at this time.
The surface active agents of the Exfoliant I solution will have completed conditioning the skin after only 1-2 minutes.
The second part of the exfoliation process utilizes the Exfoliant II solution. It is tritrated to be a more acidic solution having a pH substantially in the range of 4.3 to 4.5. Its purpose is to help neutralize the Exfoliant I and calm the skin to continue enhancement effect.
The second solution comprises a mixture of calming agents such as allantoin, comfrey, and chamomile in stabilizers such as ginger or aloe vera. The mixture is adjusted to a pH in the range of 4.3 to 4.5. Their solution is similarly applied to the skin, and any facial debris is removed preferably by a cool towel. A preferred embodiment of the Exfoliant II solution was prepared according to the invention. It contains the following:
Balm Mint Extract
Water or Demineralized
A sample procedure for using the Exfoliant II solution is as follows: First, place 1∝2cc's of the Exfoliant II solution onto two cotton pads and massage the solution slowly, with a small amount of pressure, onto the facial skin area to be treated. Lathering should occur. However, some skin will absorb the product more readily and lathering may be negligible.
Second, place a cool towel, soaked in distilled or demineralized water, around the facial area and begin slowly and softly wiping off the topical debris, making sure the towel is not too wet. Repeat until as much residue has been removed from the skin as possible. The cool towel will constrict the muscles and force sub strata toxins to the surface, and extractions may be done at this time.
Next, the cleansing step is accomplished by means of a bacteriostatic agent, such as ergocalciferal. This step may also include calming and toning and salve agents as well. The action of the cleansing solution is to perform primarily as a bacteriostatic agent against S. aureus bacteria on the skin without harming much of the beneficial E. coli. The balance of certain bacteria on the skin keeps in check certain forms of ache. In the preferred embodiment of the invention, the cleansing solution may be prepared as follows:
Sterile Distilled Water
The procedure for using the cleansing solution is as follows: First, place 2-3cc's of the cleansing solution on a clean cotton pad. Rub smoothly and continually over the surface of the skin from the neck area up.
This step is often termed “Osmotic Hydration” and involves a process of molecular dispersion to enhance the stratum corneum. A selectively semi-permeable keratinized layer is created that will allow the skin to receive a higher level of nutrients because of sub-micronic, pore-by-pore deposition. Vitamins A an E and liquid minerals are strategically placed on the skin for absorption.
An example of the molecular dispersing ingredients are shown in the following example:
Mycelated Retinol Palmitate-
Higher potency and action
(Trace Sea Derived)
Sterile Distilled Water
The procedure for using the vitamins and minerals is as follows: First, taking 2-3 drops of liquid minerals, apply to the lips and ear lobes. Second, strategically place 3 drops of mycelated retinol palmitate onto the neck, chin and forehead. Third, place 2 drops of the mycelated d-alpha tocopherol on both cheeks of the user's face and 4 drops of simmondsia cheninsis into the applicant's palm. Begin to message the vitamins and minerals slowly into the skin from the neck up.
Fourth, take sterile towelettes that have been pre-soaked and cooled in hygroscpic enzymes and place them into the neck and face.
Fifth, take a pre-heated towel and wrap the facial area. The heated towel allows for an increase in capillary action and the face is allowed time to be saturated in the applied solutions.
This step utilizes an atomizer or nebulizer (sub-micronic delivery system, or SMDS) which should generate sub-micronic particles consistently in the range of 0.5 to 0.9 microns.
Because of the variable ranges of pH changes that the skin has gone through, in the exfoliation process and now with the addition of topical radiant heat the skin has become a more semi-permeable membrane. The skin will now safely absorb a select amount of molecular nutrients on a pore-by-pore basis. More vitamins and minerals are applied for absorption. An example of the solution used in this step and placed in the SMDS for application was prepared as follows:
purified sea derived
mycelated retinol palmitate
mycelated 4-alpha tocopherol
sterile distilled water
The total amount of solution made is approximately 3 ml.
The procedure for using the oxygenation solution is as follows: First fill the SMDS to a level of 2.5 cc's with the oxygenation solution. Second, add 3 gtts each of mycelated d-alpha tocopherol and mycelated retinol palmitate into the SMDS. Should the user be a smoker, or have parched skin, add 3 gtts of simmondsia cheninsis plus an additional drop of each mycelated vitamin.
Third, close the SMDS and unwrap the heated towels from the facial area. The towelettes may be set aside for use at the end of the treatment. Fourth, turn the oxygen tank to a flow of between 5 and 6 liters/minute and begin oxygenation of the user's skin, from the neck upwards with a depth of approximately ½ inch to 1 inch. Next, make sure the SMDS is upright and at a 45 degree angle. Progressively move the SMDS over the face in small areas so that each pore is oxygenated optimally from a range of 1 inch to 1½ inches.
Continue oxygenation until the whole area is completely saturated. This should require approximately 4 to 5 minutes. When complete, turn the oxygen off and replace the SMDS. Finally, place a few drops of the bacteriostatic cleansing solution onto the towelettes that were taken from the user's face and have the user wipe their hands.
In general, oxygen is responsible for the health and maintenance of every cell in the human body, including skin cells. In today's environment, many factors play a large part in the hindrance of the oxygen molecule to these cells, both externally and internally. Therefore, in today's standard of professional skin care, it has become apparent that the future of skin care must be developed to use oxygen to better serve the millions of people concerned about preventative skin care.
Oxygen is controlled and regulated by various agencies in this country, and as such is classified as a drug. The invention is clinically unique to the field of cosmetology in that, for the first time ever, the professional aesthetician is provided with a strong nutrients base for the care of the skin that will include actual oxygen molecules. The process, as described, allows the skin to respond to and accept moisturized nutrients by an oxygenated mist in a manner not previous set forth in prior art.
It therefore can be seen that the invention accomplishes at least all of its stated objectives.
In the specification there has been set forth a preferred embodiment of the invention, and although specific terms are employed, these are used in a generic and descriptive sense only and not for the purpose of limitation. Changes in the form and the proportion of ingredients as well as in the substitution of equivalents are contemplated as circumstances may suggest or render expedient without departing from the spirit or scope of the invention as further defined in the following claims.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US123714||Feb 13, 1872||Ment of diseases by inhalation|
|US3810996||Mar 14, 1972||May 14, 1974||G Sutliff||Cosmetic preparation|
|US4743442||Nov 27, 1985||May 10, 1988||Blendax-Werke R. Schneider Gmbh & Co.||Skin care composition|
|US4751075||Jan 8, 1986||Jun 14, 1988||Redken Laboratories, Inc.||Anhydrous cosmetic compositions for thermal skin treatments|
|US4810496||Jan 27, 1986||Mar 7, 1989||Jensen Charles A||Treatment of skin and inflammatory disorders|
|US4911925||Apr 17, 1989||Mar 27, 1990||Lima Shatkina||Vegetable extracts for skin treatment|
|US4992476||Apr 4, 1988||Feb 12, 1991||Warner-Lambert Company||Skin cleansing and moisturizing composition and method of using and preparing same|
|US5063062||Sep 27, 1989||Nov 5, 1991||D. Greenspan||Cleaning compositions with orange oil|
|US5080901||Jun 23, 1989||Jan 14, 1992||Richter Gedeon Vegyeszeti Gyar Rt.||Cosmetic and paramedicinal compositions containing plant extracts|
|US5162377||Jun 15, 1989||Nov 10, 1992||Shiseido Company, Ltd.||Transparent composition|
|US5227161||Apr 4, 1991||Jul 13, 1993||Symbollon Corporation||Method to clean and disinfect pathogens on the epidermis by applying a composition containing peroxidase, iodide compound and surfactant|
|US5229130||Dec 20, 1991||Jul 20, 1993||Cygnus Therapeutics Systems||Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems|
|US5242952||Jun 16, 1992||Sep 7, 1993||Dimitrios Tritsarolis||Facial skin moisturizing composition|
|US5254331||Sep 12, 1991||Oct 19, 1993||Chanel, Inc.||Skin cream composition|
|US5516517||May 2, 1994||May 14, 1996||Exfoliation Cleansing Hydration Oxygenation Corporation||Method for nutritional oxygenation of the skin|
|CH647145A5||Title not available|
|DE484139C||Mar 17, 1927||Oct 10, 1929||Rudolf Rusteberg G M B H||Kosmetisches Mittel|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US8409628||Feb 4, 2010||Apr 2, 2013||Penguin IP Holdings, Inc.||Methods and compositions for oxygenation of skin to treat skin disorders|
|US20040166171 *||Aug 8, 2003||Aug 26, 2004||Hydron Technologies, Inc.||Method for increasing tissue oxygenation|
|US20090104237 *||Jan 24, 2008||Apr 23, 2009||Hydrogen Technologies, Inc.||Method for increasing tissue oxygenation|
|U.S. Classification||424/401, 424/94.1, 424/744, 424/736, 424/735, 424/756, 514/844, 424/747, 424/745|
|International Classification||A61Q19/00, A61K36/752, A61Q19/10, A61K8/49, A61K8/19, A61K8/20, A61K8/92, A61K8/97, A61K8/67, A61K36/886, A61K8/22, A61K36/534, A61K8/66, A61Q19/08, A61K8/64, A61K8/96, A61K36/736|
|Cooperative Classification||A61K8/922, A61K8/20, A61K2800/28, A61K8/97, A61K8/22, A61K8/66, A61K8/19, A61K2800/88, A61K8/4946, A61K8/645, A61K8/494, A61Q19/10, A61Q19/00, Y10S514/844, A61K8/965, A61K8/678, A61Q19/08, A61K8/671, A61K8/67|
|European Classification||A61Q19/00, A61K8/19, A61K8/96C, A61K8/49F1, A61K8/20, A61K8/66, A61K8/97, A61K8/67C, A61K8/22, A61K8/64C, A61K8/92C, A61K8/67, A61K8/67L, A61Q19/08, A61K8/49F, A61Q19/10|
|Feb 20, 2003||AS||Assignment|
Owner name: OXYCARE INTERNATIONAL, LLC, CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:GARDNER, JOHN P.;REEL/FRAME:013782/0326
Effective date: 20001017
|Nov 19, 2007||REMI||Maintenance fee reminder mailed|
|May 9, 2008||LAPS||Lapse for failure to pay maintenance fees|